GERD in Children With Cystic Fibrosis (NCT06617013)
Characteristics of Gastroesophageal Reflux in Children With Cystic Fibrosis
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.
Who can join: Review the eligibility criteria below.
Location: Duke University Hospital — Durham, North Carolina
Age range: 2 Years to 18 Years
🧪 Interventions in This Study
- Discontinuation of GERD therapy (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Duke University Hospital — Durham, North Carolina
📞 Contact the Study Coordinator
Phone: (919) 684-8111
Email: yara.salameh@duke.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All GERD in Children clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.